After another week of heavy blows felt by the investing community , it is becoming very clear that we have not yet reached the bottom yet. The Aussie index is still down by 13.1% after last weeks horror show and “has slumped by more than 31% over the last twenty trading sessions” Steven Daghlian from CommSec.… Read more
Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area.
If you have not heard of Paradigm BioPharmaceuticals (ASX: PAR) then today is your lucky day. PAR is an Australian BioPharmaceutical company that aims to alleviate the cartilage degradation of Osteoarthritis (OA) through their repurposed drug Zilosul.… Read more